Coffee clinical trials at UCSF
1 research study open to eligible people
Does Eliminating Coffee Avoid Fibrillation?
open to eligible people ages 21 years and up
Given both the increasing population impact of atrial fibrillation (AF) and the widespread consumption of coffee in society, determining an associated benefit or risk of coffee consumption on AF is of great clinical relevance. This pilot study will evaluate the effect of randomly assigning participants undergoing electrical cardioversion to coffee abstinence or coffee consumption over a 6 month period. This pilot study will provide the first, randomized evaluation of coffee on AF outcomes and will provide important information on whether or not coffee has any effect on AF recurrence.
San Francisco, California
Our lead scientists for Coffee research studies include Chris Wong, MD Greg Marcus, MD.